Main Component of Green Tea Extract... Helps Women with Asymptomatic Uterine Fibroids

International Pharmaceutical 'Yutris'

[Asia Economy Reporter Seo So-jeong] International Pharmaceuticals (CEO Nam Tae-hoon and Ahn Jae-man)'s auxiliary treatment for uterine fibroids, 'Utrice,' is a product recommended for women with asymptomatic uterine fibroids. International Pharmaceuticals produces, imports, and sells Delphis from the Italian pharmaceutical and health food manufacturer Lollipharma through Original Design Manufacturing (ODM).

Utrice's main ingredients are green tea extract, vitamin D, and vitamin B6. It is suitable for women with asymptomatic uterine fibroids and those who have symptomatic uterine fibroids but find surgery difficult. It has effects such as regulating fibroid growth, alleviating symptoms, and maintaining hormonal balance.

In particular, an experiment was conducted on 30 women with at least one fibroid larger than 2㎤: 15 women took one Delphis tablet twice daily for four months, while the other 15 did not take it. As a result, the Delphis intake group showed a reduction in fibroid size and menstrual bleeding, whereas the non-intake group experienced an increase in fibroid area and no change in menstrual bleeding.

The main ingredient, green tea extract, is known to help with antioxidant effects, body fat reduction, and improvement of blood cholesterol levels. There are also reports that catechins in green tea inhibit the growth of enzymes necessary for cancer cell growth.

This content was produced with the assistance of AI translation services.